טוען...
Genetic Influences in Breast Cancer Drug Resistance
Breast cancer is the most common cancer in adult women aged 20 to 50 years. The therapeutic regimens that are commonly recommended to treat breast cancer are human epidermal growth factor receptor 2 (HER2) targeted therapy, endocrine therapy, and systemic chemotherapy. The selection of pharmacothera...
שמור ב:
| הוצא לאור ב: | Breast Cancer (Dove Med Press) |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7882715/ https://ncbi.nlm.nih.gov/pubmed/33603458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S284453 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|